Mohammed Najeeb Al Hallak, MD, MS
I was in my last year of medical school in Syria when I lost my father to chronic lymphocytic leukemia. I had encouraged him to seek treatment after seeing him suffer from disease-related fatigue and early satiety because of his huge spleen. I never expected, with my limited knowledge back then, that rituximab could cause such severe tumor lysis syndrome with disseminated intravascular coagulation on the third day of its administration.
... to read the full story